$SNYRQ 3 SEC Filings

Filed On	Filing
02 Oct 2025	Form 3: Thompson Teresa Brigid, Director No securities owned
22 Oct 2024	Form 3: Knight Therapeutics Inc, 10% owner and 1 other Holds 1,482,844 shares of Common Stock, par value $0.00001 per share
22 Oct 2024	Form 3: Woodburn Scott, Director No securities owned
22 Oct 2024	Form 3: SoRelle James Paul, Director Holds 108,963 shares of Common Stock, par value $0.00001 per share
22 Oct 2024	Form 3: Kaushal Nitin, Director No securities owned
22 Oct 2024	Form 3: Ross Jack, Director Holds 326,507 shares of Common Stock, par value $0.00001 per share
22 Oct 2024	Form 3: Baumeler Alfred, Director
22 Oct 2024	Form 3: Fickett Jaime, Senior VP Finance & Operations
22 Oct 2024	Form 3: McLaughlin Stacy B., Chief Financial Officer
06 Nov 2017	Form 3: McCullough Patrick S., President
01 Nov 2017	Form 3: Kadanoff Jeffrey, Chief Financial Officer Holds 500,000 shares of Common Stock
20 Oct 2017	Form 3: Bensussen Gale K., Director No securities owned
27 Apr 2015	Form 3: Gowan Private Equity Inc., 10% owner Holds 16,522,500 shares of Common Stock, $0.00001 par value per share
10 Feb 2015	Form 3: SoRelle James Paul, Director Holds 1,296,658 shares of Common Stock
09 Feb 2015	Form 3: Fryer Stephen J, Director No securities owned
09 Feb 2015	Form 3: Ross Jack, Director Holds 3,208,649 shares of Common Stock
02 Feb 2015	Form 3: Knight Therapeutics (Barbados) Inc., 10% owner Holds 4,595,187 shares of Common Stock

Comments